Company Synopsis:

PeproTech was established in 1988 by a group of scientists who decided to focus their efforts on the development and production of recombinant cytokines for life-science research. Today, PeproTech is a world leader in supplying high quality cytokine products including E. coli, insect and mammalian cell-derived recombinant proteins, their monoclonal/polyclonal antibodies, ELISA development kits and other cytokine-related reagents. These products are distributed worldwide through customer-service offices in the USA, UK, France, Germany, Israel, Korea, Japan, Brazil and Mexico.

We plan to maintain the highly competitive pricing of our products, and to expand their distribution to Australia, New Zealand and other locations. To keep up with current research and growing demands, we have recently expanded our production capabilities to include a 5000sq.ft. animal-free manufacturing facility.

A key component in keeping up with current scientific advancements has been our collaboration with researchers in both academia and industry who provide us with suggestions necessary to continuously expand our production pipeline. We encourage you to convey to us your particular research needs and promise to do our best to fulfill them. Please contact PeproTech EC if you need additional information.